Latest results from the long-term extension of a Phase 1b study assessing increasing and fixed doses of aducanumab continue…
Articles by Alice Melão
Two recent studies highlight the relationship between age and dementia, one finding that people with dementia survive an average…
Neurotrope’s investigational compound Bryostatin-1 showed evidence of sustained improvement in cognition compared to placebo in patients with moderate-to-severe Alzheimer’s…
Biohaven Pharmaceuticals has enrolled the first patient in its Phase 2/3 clinical trial investigating the potential of trigriluzole…
The latest clinical data from Genentech on crenezumab and gantenerumab demonstrate the investigational therapies’ potential to reduce amyloid…
Results of a first, large-scale study into the prevalence of dementia among lesbian, gay, and bisexual older adults in the…
The latest data from a Phase 2 trial (study 201) demonstrates that BAN2401 can slow cognitive decline, providing additional evidence…
Low-intensity pulsed ultrasound (LIPUS) therapy applied to the whole brain can be an effective, non-invasive strategy to reduce cognitive impairment…
The process by which the tau protein is transformed from a healthy cell component into a driver of crippling diseases…
Treatment with investigational compound BAN2401 over 18 months reduced the accumulation of amyloid fibers in the brain and slowed Alzheimer’s disease progression,…